TABLE 2.
Number of countries on the African continent enrolled in GLASS and reporting AST results during the three data GLASS calls (2017–2019), as well as availability of data stratification by age, gender and infection origin and data on the number of patients from which a diagnostic sample was taken (tested).
Data call (year) | Number of countries reporting patients AST results | List of countries | Number of countries reporting additional variables (%) |
|||||||
---|---|---|---|---|---|---|---|---|---|---|
Age |
Gender |
Infection origin |
Number of tested patients |
|||||||
N | % | N | % | N | % | N | % | |||
2017 | 6 | Egypt, Madagascar, Malawi, South Africa, Tunisia, Zambia | 4 | 67 | 5 | 83 | 4 | 67 | 1 | 17 |
2018 | 9 | Egypt, Madagascar, Malawi, Nigeria, South Africa, Sudan, Tunisia, Uganda, Zambia | 8 | 89 | 9 | 100 | 4 | 44 | 6 | 67 |
2019 | 10 | Egypt, Ethiopia, Madagascar, Mali, Mozambique, Nigeria, South Africa, Sudan, Tunisia, Uganda | 10 | 100 | 10 | 100 | 7 | 70 | 10 | 100 |
GLASS, Global Antimicrobial Resistance and Use Surveillance System; AST, Antimicrobial Susceptibility Testing.